PFSA

Profusa, Inc. Common Stock · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-04-15

Figures on this page computed 2026-11-08 12:40 UTC

Last close

0.62USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-04-15

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-04-15

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD
    • 10-K for 2025, filed 2026-04-15
    • 10-K for 2025, filed 2026-04-15
    • 10-K for 2025, filed 2026-04-15
    • 10-Q for 2025, filed 2026-08-19
    • 10-K for 2025, filed 2026-04-15
    • 10-Q for 2025, filed 2026-05-15

    The filing itself

  • n/aNet margin

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD
    • 10-K for 2025, filed 2026-04-15
    • 10-K for 2025, filed 2026-04-15

    The filing itself

  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD
    • 10-K for 2025, filed 2026-04-15
    • 10-K for 2025, filed 2026-04-15

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD
    • 10-K for 2025, filed 2026-04-15
    • 10-Q for 2025, filed 2026-08-19

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

Five bars, one line

lens 7 of 9
n/a
3.81x
1.21x
n/a
0.00x
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Filed2025
Filed2025
Filed2025
Filed2025
Market data2026-11-04

Each against its own average

3 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-04-15

  • Salesn/a

    Its own average over 1 year, 100.0K.

  • Profit3.81x

    Its own average over 5 years, -9.4M.

  • Free cash flow1.21x

    Its own average over 2 years, -13.5M.

  • Debtn/a

    Its own average over 2 years, 12.1M.

  • Price0.00x

    Its own average over 2 years, 1.2K. Market data, 2026-11-04

Profit is furthest from its own average, at 3.81 times.

Profit is 3.81 times its own 5-year average; Free cash flow is 1.21 times its own 2-year average; Price is 0.00 times its own 2-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-04-15

  • Sales against its own 1-year averagen/a

    Not held.

    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD

    The filing itself

  • Profit against its own 5-year average3.81
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD

    The filing itself

  • Free cash flow against its own 2-year average1.21
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD

    The filing itself

  • Debt against its own 2-year averagen/a

    Not held.

    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0001213900-26-044046
    Reported in
    USD

    The filing itself

  • Price against its own 2-year average0.001Market data, 2026-11-04
    Source
    market
    Taken on
    2026-11-04
    Reported in
    USD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.